GeorgeCapellaGarrowMD

PubMed

• Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma.
  Kenneth R. Hande, George C. Garrow> ;The American Journal of Medicine. 1993 Feb 1
• Treatment of "good risk" metastatic testicular cancer.
  George C. Garrow, David H. Johnson> ;Seminars in Oncology. 1992 Apr 1
• Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
  Boros, L., Garrow, G. C., Asbury, R. F., Chang, A. Y.> ;Semin Oncol. 1995 Jun
• Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
  Chang, A. Y., Asbury, R. F., Boros, L., Garrow, G. C., Hsieh, S.> ;Semin Oncol. 1995 Jun
• Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
  Chang, A. Y., Garrow, G. C.> ;Semin Oncol. 1995 Apr
• Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site.
  Garrow, G. C., Greco, F. A., Hainsworth, J. D.> ;Semin Oncol. 1993 Jun
• Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
  Chang, A. Y., Boros, L., Garrow, G. C., Asbury, R. F., Hui, L.> ;Semin Oncol. 1996 Jun
• Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease.
  Chang, A. Y., Boros, L., Garrow, G., Asbury, R.> ;Semin Oncol. 1995 Jun
• Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
  Chang, A. Y., Hui, L., Asbury, R., Boros, L., Garrow, G., Rubins, J.> ;Cancer Chemother Pharmacol. 1999
• Join now to see all